No Data
shanghai rongtai health technology corporation (603579.SH): The company has cooperation with Huawei in terms of products.
Gelonghui November 12th | Shanghai Rongtai Health Technology Corporation(603579.SH) stated on the investor interaction platform that the company has been actively seeking suitable investment targets, but there is currently no relevant progress. If there is any progress, the company will disclose relevant information in a timely manner. Please pay attention to the company's subsequent developments. The company has cooperation with Huawei in terms of products.
Shanghai Rongtai Health Technology Corporation (603579): Facing fierce competition in the industry, profitability under pressure.
The company disclosed its third quarter report: In the first three quarters of 2024, the company achieved revenue of 1.164 billion yuan, a year-on-year decline of 10.30%, achieving a net income attributable to the parent company of 0.143 billion yuan, a year-on-year decline of 6.08%, achieving non-recurring items.
Shanghai Rongtai Health Technology Corporation (603579.SH): Through cooperation with XREAL company, the company will actively explore the application of advanced VR/AR technology to massage chairs or other health products.
Rongtai Health (603579.SH) stated on the investor interaction platform on October 31 that XREAL is a high-tech company focusing on virtual reality (VR) and augmented reality (AR) technology, with products and services covering hardware devices, software development, content production, and other aspects. XREAL is dedicated to providing immersive experiences for users through its technological innovation, and has applications in education, entertainment, medical, and other fields. Through cooperation with XREAL, the company will actively explore the application of advanced VR/AR technology to massage chairs or other health products.
Shanghai Rongtai Health Technology Corporation (603579): Q3 demand under pressure, cash flow has improved slightly
Event: shanghai rongtai health technology corporation announced its third quarter report for 2024. The company achieved revenue of 1.16 billion yuan in the first three quarters of 2024, -10.3% year-on-year, and achieved a net income attributable to the mother of 0.14 billion yuan, -6.1% year-on-year; after conversion,
Shanghai Rongtai Health Technology Co., Ltd. Report for the Third Quarter of 2024
shanghai rongtai health technology corporation (603579.SH): the net income for the first three quarters was 0.14 billion yuan, a year-on-year decrease of 6.08%.
On October 29, Gelonhui announced its third-quarter report, with operating revenue of 1.164 billion yuan in the first three quarters, a year-on-year decrease of 10.30%, a net income of 0.14 billion yuan, a year-on-year decrease of 6.08%, a non-net income of 0.127 billion yuan, a year-on-year decrease of 5.54%, and basic earnings per share of 0.82 yuan.
No Data
No Data